Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability

被引:0
|
作者
J J Luke
C I van de Wetering
C M Knudson
机构
[1] The University of Iowa Roy J. and Lucille P. Carver College of Medicine,Department of Pathology
[2] Molecular Biology Program,undefined
[3] The University of Iowa Roy J. and Lucille P. Carver College of Medicine,undefined
[4] Immunology Program,undefined
[5] The University of Iowa Roy J. and Lucille P. Carver College of Medicine,undefined
来源
关键词
apoptosis; oncogenesis; chromosomal instability;
D O I
暂无
中图分类号
学科分类号
摘要
Bax is a Bcl-2 family member that promotes apoptosis but has paradoxical effects on lymphoma development in p53-deficient mice. To better understand the mechanism of Bax-induced lymphoma development, the effect of Bax levels, p53 status and Bcl-2 coexpression on lymphoma development were determined. In addition, DNA content and cytogenetics were performed on young (premalignant) Lck-Bax mice as measures of genetic instability. Bax promoted lymphoma development in p53-deficient mice in a dose-dependent manner. Bax expression also led to lymphoma development in both p53 +/− and +/+ animals. Ploidy analysis in mice prior to the onset of overt thymic lymphomas demonstrated that Lck-Bax transgenic mice were more likely to be aneuploid and demonstrate increased chromosome instability. With tumor progression, aneuploidy increased and Bax expression was maintained. Importantly, coexpression of Bcl-2 delayed lymphoma development in Lck-Bax transgenic mice. These data support a model in which increased sensitivity to apoptosis leads directly to chromosome instability in developing T cells and may explain a number of paradoxical observations regarding Bcl-2 family members and the regulation of cancer.
引用
收藏
页码:740 / 748
页数:8
相关论文
共 50 条
  • [1] Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability
    Luke, JJ
    van de Wetering, CI
    Knudson, CM
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (06): : 740 - 748
  • [2] Paradoxical tumor development and chromosomal instability in Lck-Bax transgenic mice.
    Knudson, CM
    Van de Wetering, C
    Luke, J
    BLOOD, 2002, 100 (11) : 199A - 199A
  • [3] PERIPHERAL T-CELL LYMPHOMA IN LCK(PR)-BCL-2 TRANSGENIC MICE
    LINETTE, GP
    HESS, JL
    SENTMAN, CL
    KORSMEYER, SJ
    BLOOD, 1995, 86 (04) : 1255 - 1260
  • [4] Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotection
    Karlnoski, Rachel
    Wilcock, Donna
    Dickey, Chad
    Ronan, Victoria
    Gordon, Marcia N.
    Zhang, Wenru
    Morgan, Dave
    Taglialatela, Giulio
    NEUROBIOLOGY OF DISEASE, 2007, 25 (01) : 179 - 188
  • [5] Enhanced apoptosis associated with anabolic actions of androgens in AR-transgenic mice: Requirement of reduced Bcl-2/Bax ratio.
    Wiren, K
    Toombs, A
    Zhang, X
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S399 - S399
  • [6] HYBRIDOMA PRODUCTION FROM BCL-2 TRANSGENIC MICE
    KNOTT, C
    KRUSEMEIER, M
    SAEDI, MS
    KUMAR, A
    BODRUG, S
    KITADA, S
    REED, JC
    KUUSREICHEL, K
    FASEB JOURNAL, 1994, 8 (04): : A337 - A337
  • [7] Upregulation of Bcl-2 in APP transgenic mice is neuroprotective
    Karlnoski, R
    Ronan, V
    Clarke, S
    Gordon, M
    Morgan, D
    EXPERIMENTAL NEUROLOGY, 2005, 193 (01) : 248 - 249
  • [8] Bcl-2 and Bax proteins are nuclear matrix associated proteins
    Wang, ZH
    Ding, MX
    Chew-Cheng, SB
    Yun, JP
    Chew, EC
    ANTICANCER RESEARCH, 1999, 19 (6B) : 5445 - 5449
  • [9] Expression of Bcl-2, Bax and Bcl-x in the cerebellum of mutant Lurcher mice
    Wuellner, U
    Weller, M
    Loschmann, PA
    Schulz, JB
    Muller, I
    Krajewski, S
    Reed, JC
    Klockgether, T
    NEUROLOGY, 1997, 48 (03) : 6110 - 6110
  • [10] Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2
    Shitashige, M
    Toi, M
    Yano, T
    Shibata, M
    Matsuo, Y
    Shibasaki, F
    JOURNAL OF BIOCHEMISTRY, 2001, 130 (06): : 741 - 748